Addiction: the clinical interface.

British Journal of Pharmacology
David Nutt, Anne Lingford-Hughes

Abstract

This review gives an overview of what we see as the key issues in the human pharmacology of drugs of addiction. We review evidence of efficacy and mechanisms by which treatments act and point out areas where further work is needed. The role of agonist, partial agonist and antagonist treatments for opioid addiction is detailed and current issues relating to the mechanisms of actions at the receptor level and how to improve on compliance are discussed. The role of the brain dopamine and GABA-A systems in drug dependence is considered in relation to the growing pharmacology of these receptor systems, and the current status of novel preclinical targets reviewed. In addition, the different roles of dynamic and kinetic factors in both addiction and its treatment are discussed in relation to the underlying neuropharmacology of the disorders as defined from human and preclinical studies. Finally, some pointers to future research and especially to drug development by pharma are elaborated.

References

Jan 1, 1991·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·M GewissP De Witte
Jun 3, 1996·European Journal of Pharmacology·R SpanagelW Zieglgänsberger
Feb 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G J WangK Pascani
Mar 24, 1998·Annual Review of Medicine·G Tsai, J T Coyle
Mar 21, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M Laruelle
May 4, 2000·American Journal of Rhinology·A P BalbaniO Butugan
May 24, 2000·Journal of Clinical Pathology·C M Milroy, A R Forrest
Sep 26, 2000·Addiction·C LowmanD C Drummond
Mar 27, 2001·Pharmacology, Biochemistry, and Behavior·M C MhatreL P Gonzalez
Aug 8, 2001·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·W Schultz
Feb 14, 2002·Drug and Alcohol Dependence·Michael S CousinsHarriet de Wit
Mar 30, 2002·Alcoholism, Clinical and Experimental Research·Howard C Becker, Lynn M Veatch
Nov 26, 2002·Behavioural Brain Research·Gaetano Di Chiara
Jan 14, 2003·European Journal of Pharmacology·Jan K MelicharAndrea L Malizia
Feb 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Anne Lingford-Hughes, David Nutt
Aug 7, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark K GreenwaldJon-Kar Zubieta
Sep 7, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jan K MelicharDavid J Nutt
Jan 27, 2005·Journal of Psychopharmacology·David Nutt
Jul 16, 2005·Biological Psychiatry·Diana MartinezAnissa Abi-Dargham
Aug 9, 2005·Pharmacology & Therapeutics·Frank Vocci, Walter Ling
Sep 13, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·G K HulseR J Tait
Mar 1, 2006·Expert Opinion on Emerging Drugs·Mehmet Sofuoglu, Thomas R Kosten
Mar 8, 2006·Archives of General Psychiatry·Stefan G HofmannMichael W Otto
May 4, 2006·JAMA : the Journal of the American Medical Association·Raymond F AntonUNKNOWN COMBINE Study Research Group
Jun 16, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nora D VolkowChristopher Wong
Aug 23, 2006·Molecular Psychiatry·X XueiH J Edenberg
Sep 15, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dean F WongEdythe D London
Nov 18, 2006·Journal of Clinical Psychopharmacology·Helen M PettinatiCharles A Dackis

❮ Previous
Next ❯

Citations

Jul 16, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Pouya Tahsili-FahadanGary Aston-Jones
May 7, 2014·Pharmacogenomics·Marta Torrens, Francina Fonseca
Jul 16, 2010·Expert Opinion on Investigational Drugs·Marta Rodríguez-AriasJosé Miñarro
Aug 26, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Aaron M Gilson, Paul G Kreis
Jun 15, 2016·Annual Review of Nutrition·Adrian CarterWayne Hall
Oct 2, 2014·Journal of Psychopharmacology·Eduardo Ekman SchenbergDartiu Xavier da Silveira
Apr 17, 2008·British Journal of Pharmacology·A J LawrenceP W Kalivas
Sep 5, 2019·Experimental Dermatology·Yozo Ishiuji
Sep 24, 2015·Pharmacological Reports : PR·Aysu H TezcanTayfun Uzbay
May 5, 2016·The American Journal on Addictions·Mary Clare KennedyKanna Hayashi
Nov 7, 2012·British Journal of Clinical Pharmacology·Sean David HoodGary Kenneth Hulse
Nov 2, 2019·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alessandro Piccin, Angelo Contarino
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.